Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IDI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
OLFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC01297 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIK1-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL11B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF26A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FARP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PACS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PQLC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY75-CD302 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM13C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on